Clinical Trials Market 2022

Industry Size, Regions, Emerging Trends, Growth Insights, Opportunities, and Forecast By 2030

Clinical Trials Market by Phase (Phase I, Phase II, Phase III, and Phase IV), by Design (Treatment Studies and Observational Studies), by Region – Global Share and Forecast to 2030

Region: Global | Format: Word, PPT, Excel | Report Status: Published

Description

According to the Market Statsville Group (MSG), the global Clinical Trials Market size is expected to grow from USD 37,892.4 million in 2021 to USD 62,406.1 million by 2030, at a CAGR of 5.7% from 2022 to 2030.

The rising prevalence of skin infections such as eczema and psoriasis, as well as minor ailments such as acne, as well as an increase in preference for clinical trials due to their non-invasive nature, are expected to drive the clinical trials market in the coming years. The high prevalence of skin diseases and burn injuries, the deep penetration of drugs in the body, and the rise in the geriatric population are the major factors driving the Clinical Trials Market. However, the adverse effects of topical drugs, such as allergies and rashes, as well as the slow onset of action, limit the market growth. Factors such as transdermal biologic delivery and the acquisition of small market players are expected to present numerous opportunities for market growth in the forecast period.

Global Clinical Trials Market Definition

Clinical trials are also used to try to invent ways to detect a disease in its early stages, sometimes before its symptoms affect the body. Clinical trials are also used to test ways to prevent a health problem. Clinical trials may also assess the efficacy of methods to improve the physical condition of people suffering from a potentially fatal disease or a chronic health problem. It also investigates the role of caregivers or support groups on occasion. Prior to the U.S. Food and Drug Administration (FDA) approved clinical trials, scientists conducted laboratory tests and studies on animal models to test the safety and efficacy of a potential drug. The FDA may approve the intervention to be tested in humans based on the success rate of these preliminary results.

COVID-19 Impact on the Global Clinical Trials Market

The COVID-19 pandemic has significantly impacted the clinical trial market, as there has been a growing emphasis on developing new therapeutics or vaccines to prevent or treat the disease. Furthermore, COVID-19 has caused a minor shift in how clinical trials are conducted. In the clinical trial space, there has been increased interest in virtual/decentralized trials, which have been featured on conference agendas and in magazine articles for a long time. Despite this, most businesses continue to use the same processes. However, COVID-19 has forced some trials to switch to a virtual model to stay on track during the pandemic.

Global Clinical Trials Market Dynamics

Drivers: Increasing investment in pharmaceutical research and development

Most biopharmaceutical and medical device companies continue to make significant investments in developing new drugs and devices. Pharmaceutical companies invest in R&D in order to bring high-quality, innovative products to market. According to trends, top pharma companies are increasing their R&D efficiencies through heavy R&D investments (for long-term returns) and collaborative R&D efforts. The aforementioned issues are driving businesses to look for fully integrated or operational outsourcing services for drug research and development, from the early stages of research through the late-stage development phase, thereby accelerating market expansion.

Opportunities: Novel clinical trial designs for complex cell and gene therapies are required

In the treatment of various diseases, cell and gene therapies have the potential to meet unmet medical needs due to their great specificity. Many pharmaceutical investors and companies have dedicated extensive resources to developing and marketing these medicines due to their remarkable therapeutic potential. More than six gene therapy products were approved in various countries as of 2018. The US FDA had approved 16 cell and gene therapies as of April 2021. Around 362 cell and gene therapies were in clinical trials by 2020. The increasing number of cell therapy candidates, combined with their rapid progression through the various stages of clinical development, is driving up demand for facilities that provide R&D services for these therapies.

Scope of the Global Clinical Trials Market

The study categorizes the clinical trials market based on phase, services, therapy area, and application at regional and global levels.

By Phase Outlook (Sales, USD Million, 2017-2030)

  • Phase I
  • Phase II
  • Phase III
  • Phase IV

By Service Outlook (Sales, USD Million, 2017-2030)

  • Protocol Designing
  • Site Identification
  • Patient Recruitment
  • Laboratory Services
  • Bioanalytical Testing Services
    • Cell-based Assays
    • Virology Testing
    • Method Development, Optimization, & Validation
    • Serology, Immunogenicity, & Neutralizing Antibodies
    • Biomarker Testing Services
    • PK/PD (Pharmacokinetics/Pharmacodynamics) Testing Services
    • Others
  • Analytical Testing Services
  • Clinical Trial Supply & Logistic Services
  • Decentralized Clinical Services
  • Clinical Trial Data Management Services
  • Medical Device Testing Services
  • Others

By Therapy Area Outlook (Sales, USD Million, 2017-2030)

  • Oncology
  • Infectious Diseases
  • Cardiology
  • Neurology
  • Women's Health
  • Genetic Diseases
  • Immunology
  • Others

By Application Outlook (Sales, USD Million, 2017-2030)

  • Vaccine
  • Cell & Gene Therapy
  • Small Molecules
  • Others

By Region Outlook (Sales, USD Million, 2017-2030)

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • Italy
    • France
    • UK
    • Spain
    • Poland
    • Russia
    • The Netherlands
    • Norway
    • Czech Republic
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Indonesia
    • Malaysia
    • Thailand
    • Singapore
    • Australia & New Zealand
    • Rest of Asia Pacific
  • South America
    • Brazil
    • Argentina
    • Colombia
    • Rest of South America
  • The Middle East & Africa
    • Saudi Arabia
    • UAE
    • South Africa
    • Northern Africa
    • Rest of MEA

North America accounted for the largest market share by Region

Based on the regions, the global clinical trials market has been segmented across North America, Asia-Pacific, Europe, South America, and the Middle East & Africa. North America accounts for the highest market share in 2021 and is expected to maintain its dominance throughout the forecast period. Due to increased R&D investments and increased adoption of new technologies in clinical trials in this region. Market participants, such as IQVIA and PRA Health Sciences, for instance, are implementing virtual services at different stages of clinical trials, which is anticipated to drive regional market growth. Furthermore, favorable government support for clinical trials in the US market is expected to boost demand. In March 2020, the FDA launched the Coronavirus Treatment Acceleration Program (CTAP) for potential therapies to accelerate the development of treatments for coronavirus-caused global diseases. The program uses every available method to get novel treatments to patients as soon as possible while determining whether they are harmful or beneficial.

Key Market Players in the Global Clinical Trials Market

The global clinical trials market is highly competitive, with key industry players adopting strategies such as product development, partnerships, acquisitions, agreements, and expansion to strengthen their market positions. Most market companies focus on expanding operations across regions, augmenting their capabilities, and building strong partner relations.

Key major players in the global clinical trials market are:

  • IQVIA
  • LabCorp
  • Medpace Holdings
  • Novo Nordisk A/S
  • Eli Lilly and Company
  • Pfizer
  • Clinipace
  • PAREXEL International Corporation
  • Pharmaceutical Product Development, LLC
  • Charles River Laboratory
  • ICON Plc
  • PRA Health Sciences
  • Syneos Health

Key Issues Addressed

  • What is the market size by various segmentation of the clinical trials by region and its respective countries?
  • What are the customer buying behavior, key takeaways, and Porter's 5 forces of the clinical trials market?
  • What are the key opportunities and trends for manufacturers involved in the clinical trials supply chain?
  • What are the fundamental dynamics (drivers, restraints, opportunities, and challenges) of the market?
  • What and how regulations, schemes, patents, and policies are impacting the growth of the market?
  • What are the upcoming technological solutions influencing market trends? How will existing companies adapt to the new change in technology?
  • The market player positioning, top winning strategies by years, company product developments, and launches will be?
  • How has COVID-19 impacted the demand and sales of clinical trials in the global market? Also, the expected BPS drop or rise count of the market and market predicted recovery period.
  • Detailed analysis of the competitors and their latest launch, and what are the prominent startups introduced in the target market? Also, detailed company profiling of 25+ leading and prominent companies in the market.

Frequently Asked Questions

  • Key Issues Addressed
  • What is the market size and growth rate for different segmentations at a global, regional, & country level?
  • What is the customer buying behavior, key takeaways, and Porter's 5 forces of the market?
  • What are the key opportunities and trends for manufacturers involved in the supply chain?
  • What are the fundamental dynamics (drivers, restraints, opportunities, and challenges) of the market?
  • What and how regulations, schemes, patents, and policies are impacting the growth of the market?
  • How will existing companies adapt to the new change in technology?
  • The market player positioning, top winning strategies by years, company product developments, and launches will be?
  • How has COVID-19 impacted the demand and sales of in the market? Also, the expected BPS drop or rise count of the market and market predicted recovery period.
  • Who are the leading companies operating in the market? Also, who are the prominent startups that disrupt the market in coming years?
  • PUBLISHED ON: Dec, 2022
  • BASE YEAR: 2022
  • STUDY PERIOD: 2019-2033
  • COMPANIES COVERED: 15
  • COUNTRIES COVERED: 24
  • NO OF PAGES: 175

Want to Review Complete Market Research Report

 
save 20%
$2450 $1950
 
save 25%
$4450 $3338
 
save 30%
$5850 $4095
 
save 35%
$8150 $5298

Budget constraints? Get in touch with us for special pricing

Request for Special Pricing

Customize this Report

  • Buy specific region or segment sections of this report
  • Buy specific region/country level reports
  • Request for Pricing Analysis, Market Dynamics, Recommendation & Conclusion
  • Companies Profiles based on Target Requirement
  • Competitive Landscape as per Your Requirement
  • Other Specific Requirement on Customization
  • Why Choose Market Statsville Group?
  • CXO’s Perspective
  • Real-Time Market AttractivenessIndex
  • Investment Pockets
  • Market Player Positioning
  • Competitive Heatmap
  • Parent &Peer Market Analysis
  • Primary Survey Analysis & Transcripts
  • Premium insights from industry experts
  • Robust Research Methodology
  • Market Trends & Opportunities
  • Market Growth Dynamics
  • Value/Supply Chain Analysis
  • Pre-&-Post Covid Market Scenario
  • Latest Technological Developments
  • Comprehensive Reports
  • 3-Rounds Quality Checks with Complete Assurance
  • Unlimited Post-Sales Support
  • Regular Report Updates
Didn't Get What you are looking for. Share your requirements here
Request for Customization

We use cookies to enhance your experience. By continuing to visit this site you agree to our use of cookies. I Accept